Healthtech - Thematic Research

Healthtech - Thematic Research

  • Products Id :- GDHC-TR-S003
  • |
  • Pages: 32
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Healthtech-Thematic Research




Global healthcare industry is worth USD 8 trillion. At over USD 10,000 per capita, US healthcare spending is 30% higher than the world's second highest spender-Switzerland-and approximately 6.5 times higher than levels in China. Because of this higher spending, the implication is that the US healthcare sector is wasteful.


There has been a surge of interest in whether or not better technology might extract greater efficiency gains. Thus far, the global healthcare industry-especially the US healthcare industry-has been slow to modernize due to the fact that the industry is complex, risk averse, and highly regulated.


The Internet of Things (IoT) is transforming the healthcare industry. Organizations are utilizing IoT technologies to access real-time data and gain visibility into their operations throughout the manufacturing value chain. For hundreds of years, the key drivers of progress in healthcare were biology and chemistry. Now, they are data science and software.


The global IoT devices market in the healthcare sector is expected to grow at a Compound Annual Growth Rate (CAGR) of 47.3% from 2016 to 2020, to over USD 500M. One important market driver that is propelling the wider adoption of IoT in healthcare is the convergence of Big Data and IoT, which opens up significant opportunities for the industry overall. Big Healthcare is being gradually undermined by swelling networks of connected biosensors, ubiquitous mobile devices, and cloud-based healthcare apps. Collectively, these phenomena are grouped under the umbrella term, The Internet of Healthcare Things.


Six broad technology categories are set to transform the healthcare industry over the next two years: Genomics, Mobile Health, Health Information Technology (IT) Systems, Robotics, Virtual Reality,and 3D Printing. Unless major investment are carried out, in the long term the losers will be Big Pharma and Big Medical Equipment players. However, in the short term, the threat level for these companies is low.


The report "Healthtech-Thematic Research", is part of an ecosystem of thematic investment research reports.The report offers in-depth research intoHealthtech; identifying winners and losers based on technology leadership, market position and other factors.


Companies Mentioned: Qualcomm, Proteus Digital Health, Oxford, Nanopore, Medtronic, Illumina, iCarbonX, IBM Watson,, Fitbit, First Sensor, Enlitic, Cyberdyne, Cerner, Biovotion, BGI Shenzhen, AtomWise, Apple, Alphabet, AliveCor, Agendia, 23andMe




This report is part of our ecosystem of thematic investment research reports, supported by our thematic engine. About our Thematic Research Ecosystem-

- GlobalData has developed a unique thematic methodology for valuing technology, media and telecom companies based on their relative strength in the big investment themes that are impacting their industry. Whilst most investment research is underpinned by backwards looking company valuation models, GlobalData's thematic methodology identifies which companies are best placed to succeed in a future filled with multiple disruptive threats. To do this, GlobalData tracks the performance of the top 600 technology, media and telecom stocks against the 50 most important themes driving their earnings, generating 30,000 thematic scores. The algorithms in GlobalData's thematic engine help to clearly identify the winners and losers within the TMT sector. Our 600 TMT stocks are categorised into 18 sectors. Each sector scorecard has a thematic screen, a risk screen and a valuation screen. Our thematic research ecosystem has a three-tiered reporting structure: single theme, multi-theme and sector scorecard. This report is a Multi-Theme report, covering all stocks, all sectors and all themes, giving readers a strong sense of how everything fits together and how conflicting themes might interact with one another.


Reasons to buy


- Our thematic investment research product, supported by our thematic engine, is aimed at senior (C-Suite) executives in the corporate world as well as institutional investors.

- Corporations: Helps CEOs in all industries understand the disruptive threats to their competitive landscape

- Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TMT.

- Our unique differentiator, compared to all our rival thematic research houses, is that our thematic engine has a proven track record of predicting winners and losers.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents




Prevention 7

Diagnosis 8

Treatment 8

Monitoring 8

Recording 9



Genomics 11

Mobile Health 13

Health IT Systems 14

Robotics 17

Virtual and Augmented Reality 18

3D Printing 19


Digital Health Highlights Across Major Therapy Areas in 2017 22

Oncology 22

Immunology 22

Neurology 23

Ophthalmology 23

Cardiovascular and Metabolic Disorders 24

Infectious Diseases 25


Public Companies 27

Private Healthtech Companies 29


Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]





First Sensor


IBM Watson








BGI Shenzhen






Proteus Digital Health

select a license
Single User License
USD 1950 INR 134550
Site License
USD 3900 INR 269100
Corporate User License
USD 5850 INR 403650



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]